Seed Therapeutics is pioneering the science of improving human health by creating “molecular glues”: novel therapeutics that degrade disease-causing proteins that have heretofore remained “undruggable.”
Through ongoing collaborations with world-leading academic experts in the field, and in partnership with seasoned drug development and commercialization experts, Seed Therapeutics is establishing a growing pipeline of exciting drug candidates on a path to clinical and commercial success.
Our mission is to positively impact human health by creating novel protein degradation therapeutics for the treatment of severe diseases for which health care professionals currently have limited options to offer to patients.
Company Details
- Employees
- 20
- Address
- 28 Liberty St,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.SeedTherapeutics.com
- Keywords
- Biotechnology, Biotherapeutics, Cell biology, Protein chemistry, Cell pharmacology, Molecular biology, Protein degradation, Molecular glue, Targeted protein degradation.
- HQ
- New York, New York
Seed Therapeutics Questions
Seed Therapeutics's website is http://www.SeedTherapeutics.com
Seed Therapeutics's LinkedIn profile is https://www.linkedin.com/company/seed-therapeutics
Seed Therapeutics has
20 employees.
View email and phone details for 20
employees at Seed Therapeutics.
Seed Therapeutics's industry is
Biotechnology Research
Seed Therapeutics's top competitors are
Mbx Biosciences, Inc.,
Shinobi Therapeutics,
Script Biosciences,
Precigen,
Red Queen Therapeutics,
Tenax Therapeutics,
Beyondspring,
Zevra Therapeutics,
Nammi Therapeutics, Inc.,
Regel Therapeutics.
Seed Therapeutics's categories are Biotechnology Research
